Bayesian Capital Management, LP Envista Holdings Corp Transaction History

Bayesian Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$32.84 - $42.5 $216,744 - $280,500	-6,600 Reduced 19.36%	27,494 $1.12 Million
Q4 2022 Feb 14, 2023	BUY	$32.54 - $37.99 $1.11 Million - $1.3 Million	34,094 New	34,094 $1.15 Million
Q2 2022 Aug 15, 2022	SELL	$35.59 - $48.1 $184,498 - $249,350	-5,184 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$41.4 - $50.9 $214,617 - $263,865	5,184 New	5,184 $253,000
Q3 2021 Nov 15, 2021	SELL	$39.75 - $44.09 $504,825 - $559,943	-12,700 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$40.83 - $45.48 $84,150 - $93,734	2,061 Added 19.37%	12,700 $549,000
Q1 2021 May 14, 2021	BUY	$32.95 - $41.63 $350,555 - $442,901	10,639 New	10,639 $434,000

315

200M

128K

52.4K

Ticker NVST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 163,391,008
Market Cap $3.13B
Description
Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.